UPDATE: JPMorgan Upgrades Infinity Pharmaceutical (INFI) to Neutral
Tweet Send to a Friend
(Updated - February 5, 2021 4:56 AM EST)
JPMorgan analyst Anupam Rama upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
